| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| flunarizine | voltage-gated calcium channel alpha cav2.1 | NA | Successful target | TTD , DGIDB | Vertigo[MeSHID:D014717] Epilepsy[MeSHID:D004827] Peripheral Vascular Diseases[MeSHID:D016491] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.64 | approved | unknown |
| flunarizine | voltage-dependent t-type calcium channel subunit alpha-1g | small molecule | NA | drugbank , DGIDB | Vertigo[MeSHID:D014717] Epilepsy[MeSHID:D004827] Peripheral Vascular Diseases[MeSHID:D016491] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.12 | approved | inhibitor |
| flunarizine | voltage-gated calcium channel alpha cav3.2 | NA | Successful target | TTD , DGIDB | Vertigo[MeSHID:D014717] Epilepsy[MeSHID:D004827] Peripheral Vascular Diseases[MeSHID:D016491] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.02 | approved | unknown |
| flunarizine | voltage-dependent t-type calcium channel subunit alpha-1h | small molecule | NA | drugbank , DGIDB | Vertigo[MeSHID:D014717] Epilepsy[MeSHID:D004827] Peripheral Vascular Diseases[MeSHID:D016491] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.02 | approved | inhibitor |
| flunarizine | voltage-dependent t-type calcium channel subunit alpha-1i | small molecule | NA | drugbank , DGIDB | Vertigo[MeSHID:D014717] Epilepsy[MeSHID:D004827] Peripheral Vascular Diseases[MeSHID:D016491] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.12 | approved | inhibitor |
| flunarizine | calmodulin | small molecule | NA | drugbank , DGIDB | Vertigo[MeSHID:D014717] Epilepsy[MeSHID:D004827] Peripheral Vascular Diseases[MeSHID:D016491] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
14.14 | approved | antagonist |
| flunarizine | histamine h1 receptor | small molecule | NA | drugbank , DGIDB | Vertigo[MeSHID:D014717] Epilepsy[MeSHID:D004827] Peripheral Vascular Diseases[MeSHID:D016491] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.23 | approved | antagonist |
| click here to return to the previous page | ||||||||